Drug Profile


Alternative Names: D 19466

Latest Information Update: 13 May 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Zentaris
  • Class Antineoplastics; Cyclobutanes; Platinum complexes; Small molecules
  • Mechanism of Action Alkylating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Breast cancer; Chronic myeloid leukaemia; Small cell lung cancer
  • Discontinued Cancer

Most Recent Events

  • 13 May 2011 No development reported - Phase-II for Breast cancer in Canada (IV)
  • 13 May 2011 No development reported - Phase-II for Chronic myeloid leukaemia in Canada (IV)
  • 13 May 2011 No development reported - Phase-II for Small cell lung cancer in Canada (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top